WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
We conducted a prospective molecular study of RET, EDNRB, and EDN3 on all patients, as well as SOX10 in Waardenburg Syndrome type 4 forms.
|
28276298 |
2019 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A de novo deletion mutation in SOX10 in a Chinese family with Waardenburg syndrome type 4.
|
28128317 |
2017 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Identification of a de novo mutation of SOX10 in a Chinese patient with Waardenburg syndrome type IV.
|
27863645 |
2016 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SOX10 were first associated with Waardenburg-Hirschsprung disease (WS4; deafness, pigmentation defects and intestinal aganglionosis).
|
26060192 |
2015 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, the WS4 family carries an insertion of 19 nucleotides in exon 5 of SOX10, which results in distinct phenotypes along three different generations: hypopigmentation in the maternal grandmother, hearing loss in the mother, and WS4 in the proband.
|
24311220 |
2014 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Interestingly, the WS4 family carries an insertion of 19 nucleotides in exon 5 of SOX10, which results in distinct phenotypes along three different generations: hypopigmentation in the maternal grandmother, hearing loss in the mother, and WS4 in the proband.
|
24311220 |
2014 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
The expression patterns of some of the known SOX10 enhancers in animal models led to the speculation that endophenotypes of WS4 may be linked to mutations within some of these sequences.
|
24357527 |
2014 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the EDNRB gene, EDN3 gene, or SOX10 gene are responsible for WS4.
|
24440785 |
2014 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here, we searched for deletions within recently identified SOX10 regulatory sequences and describe the first characterization of a WS4 patient presenting with a large deletion encompassing three of these enhancers.
|
22378281 |
2012 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
Here, we searched for deletions within recently identified SOX10 regulatory sequences and describe the first characterization of a WS4 patient presenting with a large deletion encompassing three of these enhancers.
|
22378281 |
2012 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this study we describe a case of a term infant with the neurological variant of Waardenburg syndrome type 4 (i.e., PCWH = peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease, as defined in OMIM #609136) due to a novel heterozygous base exchange (c.671C>G) in exon 4 of SOX10.
|
22246888 |
2012 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In addition, the EDNRB, EDN3 and SOX10 genes were sequenced in order to identify the pathogenic mutation responsible for the WS4 observed in these patients.
|
21531202 |
2011 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
We describe a male infant with a novel SOX10 mutation and a severe course of PCWH--a special phenotype of Shah-Waardenburg syndrome involving peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung's disease.
|
21822601 |
2011 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SOX10 are associated with several neurocristopathies such as Waardenburg syndrome type IV (WS4), a congenital disorder characterized by the association of hearing loss, pigmentary abnormalities, and absence of ganglion cells in the myenteric and submucosal plexus of the gastrointestinal tract, also known as aganglionic megacolon or Hirschsprung disease (HSCR).
|
20130826 |
2010 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
The involvement of SOX10 and ZFHX1B in Waardenburg-Hirschsprung disease (hypopigmentation, deafness, and absence of enteric ganglia) and Mowat-Wilson syndrome (mental retardation, facial dysmorphy and variable congenital malformations including Hirschsprung disease) respectively, highlighted the importance of both transcription factors during enteric nervous system (ENS) development.
|
20206619 |
2010 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we examine the otic phenotype of zebrafish sox10 mutants, a model for WS4.
|
19132125 |
2009 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The present phenotype and the genotype findings underline the wide spectrum of SOX10 gene implication in unusual type 4 Waardenburg syndrome patient.
|
18348267 |
2008 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Shah-Waardenburg syndrome and PCWH associated with SOX10 mutations: a case report and review of the literature.
|
16504559 |
2006 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SOX10 mutations contribute to syndromic HSCR cases and Sox10 alleles in mice exhibit aganglionosis and pigmentary anomalies typical of a subset of HSCR patients categorized as Waardenburg-Shah syndrome (WS4, OMIM 277580).
|
15843399 |
2005 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A number of SOX10 mutations have been identified in WS4 patients who suffer from different extents of intestinal aganglionosis, pigmentation, and hearing abnormalities.
|
14523991 |
2003 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
Mutations in human Sox10 gene have also been linked with the occurrence of neurocristopathies in the Waardenburg-Shah syndrome type IV (WS-IV), for which the Sox10(Dom) mice serve as a murine model.
|
12789277 |
2003 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In contrast with the SOX10 loss-of-function mutations causing only WS4, mutations associated with both peripheral and central dysmyelination may affect pathology through a dominant-negative mechanism.
|
12447940 |
2002 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SOX10 result in Waardenburg syndrome type 4.
|
12036907 |
2002 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A SOX10 mutation was identified in an infant with Shah-Waardenburg's syndrome, and he showed persistent bowel malfunction.
|
11685702 |
2001 |
WAARDENBURG SYNDROME, TYPE 4A
|
0.500 |
Biomarker
|
disease |
BEFREE |
Moreover, haploinsufficiency of Sox10 results in neural crest defects that cause Waardenburg/Hirschsprung disease in humans.
|
11641219 |
2001 |